Д. С. Абрамов

715 total citations
56 papers, 169 citations indexed

About

Д. С. Абрамов is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Д. С. Абрамов has authored 56 papers receiving a total of 169 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 19 papers in Oncology and 16 papers in Immunology. Recurrent topics in Д. С. Абрамов's work include Lymphoma Diagnosis and Treatment (24 papers), Immunodeficiency and Autoimmune Disorders (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Д. С. Абрамов is often cited by papers focused on Lymphoma Diagnosis and Treatment (24 papers), Immunodeficiency and Autoimmune Disorders (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Д. С. Абрамов collaborates with scholars based in Russia, Germany and United States. Д. С. Абрамов's co-authors include Anna Shcherbina, Wolfram Klapper, Д. М. Коновалов, Alexandra Laberko, Michael Maschan, Ilske Oschlies, Dmitry Balashov, Yulia Rodina, Martin Zimmermann and Elena Deripapa and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Д. С. Абрамов

39 papers receiving 165 citations

Peers

Д. С. Абрамов

PFM

IMMUN

ONCOL

HEMAT

Fatma Visal Okur Türkiye

Cristina Castilla‐Llorente France

Krisztián Kállay Hungary

I Nolte Netherlands

Masanori Kadowaki Japan

Giorgia Saporiti Italy

Mahmoud Sarhan Jordan

Anthony Sabulski United States

Annie Brion France

Éric Fortin United States

Fatma Visal Okur Türkiye

Д. С. Абрамов

60 ×0.8

PFM

45 ×0.8

IMMUN

55 ×1.2

ONCOL

27 ×0.8

HEMAT

29 ×1.0

Citations per year, relative to Д. С. Абрамов Д. С. Абрамов (= 1×) peers Fatma Visal Okur

Countries citing papers authored by Д. С. Абрамов

Since Specialization

Citations

This map shows the geographic impact of Д. С. Абрамов's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Д. С. Абрамов with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Д. С. Абрамов more than expected).

Fields of papers citing papers by Д. С. Абрамов

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Д. С. Абрамов. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Д. С. Абрамов. The network helps show where Д. С. Абрамов may publish in the future.

Co-authorship network of co-authors of Д. С. Абрамов

This figure shows the co-authorship network connecting the top 25 collaborators of Д. С. Абрамов. A scholar is included among the top collaborators of Д. С. Абрамов based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Д. С. Абрамов. Д. С. Абрамов is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Абрамов, Д. С., et al.. (2024). The prognostic value of <i>TP53</i> mutational status in children with Burkitt lymphoma treated according to the B-NHL-2010M protocol. Pediatric Hematology/Oncology and Immunopathology. 23(1). 56–62.

Komkov, Alexander, Д. С. Абрамов, А. М. Попов, et al.. (2023). Unusual Presentation of SET::NUP214-Associated Concomitant Hematological Neoplasm in a Child—Diagnostic and Treatment Struggle. International Journal of Molecular Sciences. 24(19). 14451–14451. 1 indexed citations

Абрамов, Д. С., et al.. (2022). Clinical case — neoplasm of the nasal septum, which turned out to be papillary cancer of the ectopic thyroid gland. Russian Bulletin of Otorhinolaryngology. 87(2). 76–76. 1 indexed citations

Au-Yeung, Rex, Julia Richter, Ingram Iaccarino, et al.. (2021). Molecular features of non‐anaplastic peripheral T‐cell lymphoma in children and adolescents. Pediatric Blood & Cancer. 68(11). e29285–e29285. 10 indexed citations

Roppelt, Anna, et al.. (2021). Clinical case of type I interferonopathy: homozygous STAT2 gain-of-function mutation. Pediatric Hematology/Oncology and Immunopathology. 20(3). 132–139.

Olshanskaya, Yulia, et al.. (2021). Essential thrombocythemia in children and adolescents — analysis of 31 cases. 66(4). 480–498.

Pavlova, Anna, et al.. (2021). THE MANY FACES OF AUTOINFLAMMATION: ADENOSINE DEAMINASE 2 (DADA2) DEFICIENCY IN A 12 YEAR OLD. PEDIATRIA Journal named after G N SPERANSKY. 100(2). 246–253. 1 indexed citations

Абрамов, Д. С., et al.. (2021). Nodular lymphocyte-predominant Hodgkin Lymphoma in children. Retrospective clinical and morphological analysis of the patients. One Center experience. Pediatric Hematology/Oncology and Immunopathology. 20(2). 111–120.

Ovsyannikov, D.Yu., et al.. (2020). MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN ASSOCIATED WITH NEW CORONAVIRUS INFECTION (COVID-19): CLINICAL AND MORPHOLOGICAL COMPARISONS. PEDIATRIA Journal named after G N SPERANSKY. 99(6). 119–126. 2 indexed citations

10.

Абрамов, Д. С., et al.. (2020). Thymic carcinoma in a 2-year-old child: case description and literature review. Russian Journal of Pediatric Hematology and Oncology. 7(3). 112–118.

11.

Абрамов, Д. С., et al.. (2019). Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues. SHILAP Revista de lepidopterología. 12(2). 154–164. 3 indexed citations

12.

Balashov, Dmitry, Alexandra Laberko, Anna Shcherbina, et al.. (2018). A Conditioning Regimen with Plerixafor Is Safe and Improves the Outcome of TCRαβ+ and CD19+ Cell-Depleted Stem Cell Transplantation in Patients with Wiskott-Aldrich Syndrome. Biology of Blood and Marrow Transplantation. 24(7). 1432–1440. 20 indexed citations

13.

Абрамов, Д. С., et al.. (2017). Use of crizotinib for refractory ALK-positive lymphomas. Terapevticheskii arkhiv. 89(7). 51–56. 2 indexed citations

14.

Deripapa, Elena, Dmitry Balashov, Yulia Rodina, et al.. (2017). Prospective Study of a Cohort of Russian Nijmegen Breakage Syndrome Patients Demonstrating Predictive Value of Low Kappa-Deleting Recombination Excision Circle (KREC) Numbers and Beneficial Effect of Hematopoietic Stem Cell Transplantation (HSCT). Frontiers in Immunology. 8. 807–807. 25 indexed citations

15.

Абрамов, Д. С., et al.. (2017). Primary diffuse large B-cell lymphoma of the central nervous system (case report and literature review). Oncohematology. 12(1). 10–16. 2 indexed citations

16.

Абрамов, Д. С., et al.. (2016). MOLECULAR BIOLOGICAL CHARACTERISTICS OF ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA. Oncohematology. 11(4). 25–31. 3 indexed citations

17.

Белогурова, М. Б., et al.. (2015). Treatment of B-cells non-Hodgkin lymphomas with combined immunochemotherapy: ability to treatment optimization. SHILAP Revista de lepidopterología. 10(4). 15–24. 5 indexed citations

18.

Rosołowski, Maciej, Jürgen Läuter, Д. С. Абрамов, et al.. (2013). Massive Transcriptional Perturbation in Subgroups of Diffuse Large B-Cell Lymphomas. PLoS ONE. 8(11). e76287–e76287. 6 indexed citations

19.

Абрамов, Д. С., Ilske Oschlies, Martin Zimmermann, et al.. (2013). Expression of CD8 is associated with non-common type morphology and outcome in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Haematologica. 98(10). 1547–1553. 11 indexed citations

20.

Oschlies, Ilske, Birgit Burkhardt, Catherine Chassagne‐Clément, et al.. (2011). Diagnosis and Immunophenotype of 188 Pediatric Lymphoblastic Lymphomas Treated Within a Randomized Prospective Trial. The American Journal of Surgical Pathology. 35(6). 836–844. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact